Erratum to microRNA-221 promotes proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) by targeting tissue inhibitor of metalloproteinases-3 (TIMP3)
Erratum to: Cardiovasc Diagn Ther 2020;10:646-57
This article (1) titled “MicroRNA-221 promotes proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) by targeting tissue inhibitor of metalloproteinases-3 (TIMP3)” (doi: 10.21037/cdt-20-328), unfortunately contained two incorrect representative images of migration of PASMCs (Figure 4A: miR-221 inhibitor + NC siRNA group; and Figure 4B: miR-221 mimic + TIMP3 siRNA group). The authors apologize that at the time of figure assembly, they chose representative images by mistake. All original data were checked, and the results and conclusion of this article remain correct. Corrected Figure 4 is presented below.
The authors apologize for the mistake.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Yan Y, Xu Y, Ni G, et al. MicroRNA-221 promotes proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) by targeting tissue inhibitor of metalloproteinases-3 (TIMP3). Cardiovasc Diagn Ther 2020;10:646-57. [Crossref] [PubMed]
